PodcastThe Heart of Healthcare | A Digital Health PodcastOctober 21, 2026
What It Took to Tell the Truth About Theranos | Whistleblower Tyler Shultz
Theranos's fraud succeeded on storytelling and a complicit board, not technology—and Shultz argues financially rewarding whistleblowers better protects investors.
- Theranos launched with zero validated tests: Tyler Shultz says on his first day (the Walgreens launch day), the device—an eight-channel pipette on a robotic arm nicknamed 'Normandy'—had no proprietary tech; reagents and parts were bought off the shelf.
- Culture of fear silenced everyone: Shultz says every employee he knew recognized the fraud but stayed silent after witnessing public firings, lawsuits against departed staff, and company-wide threatening emails.
The full card is a free trial away.
The full summary and the deep dive on this episode, plus a brief every morning on the shows and companies you follow.
Read free — start your trial14-day free trial
Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.
